Large-volume paracentesis is a treatment used to remove excess fluid in the abdominal cavity resulting from such conditions as cirrhosis of the liver or cardiac failure. It is normally performed as an ...

The alfa pump® system received U.S. FDA Premarket Approval in December 2024 for the treatment of recurrent or refractory ascites due to liver cirrhosis. It is the first active implantable medical ...

Paracentesis is the standard treatment for refractory ascites in patients with cirrhosis, but it cannot prevent the recurrence of ascites. The placement of a transjugular intrahepatic portosystemic ...

DUBLIN--(BUSINESS WIRE)--The "Centesis Catheters Market by Type (Small and Large Bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative Care ...

The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of recurrent or refractory ascites due to cirrhosis, according to a company press release.

Dublin, June 08, 2020 (GLOBE NEWSWIRE) -- The "Centesis Catheters Market by Type (Small and Large Bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics ...

Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...

Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that are life threatening and require ...